The Parker Institute touts early results in pancreatic cancer trial — and a new model to accelerate drug development

By ADAM FEUERSTEIN

JONATHAN LEIBSON/GETTY IMAGES FOR PARKER MEDIA

The results, which come just a year and a half after the first patient was enrolled in the study, show tumor shrinkage from a multi-drug regimen.

READ MORE